Cambridge Investment Research Advisors
GHSI

Cambridge Investment Research Advisors’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-845
Closed -$51K – 2796
2020
Q3 		$51K Buy
+845
New +$87.5K ﹤0.01% 2446

Other funds holding GHSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LNWWM
Laird Norton Wetherby Wealth Management San Francisco, California $2.45B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cambridge Investment Research Advisors's GHSI Position: Q4 2020 in Review

Cambridge Investment Research Advisors sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2020, closing a stake of 845 shares — an estimated $51K sold.

Cambridge Investment Research Advisors first reported a position in GHSI in Q3 2020 and held it in 1 quarter. The position peaked at $51K in Q3 2020. 18 funds tracked by Wall St. Rank hold GHSI as of Q4 2020.

  • Cambridge Investment Research Advisors reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 845 Guardion Health Sciences, Inc. Common Stock shares in Q4 2020, an estimated $51K.
  • Cambridge Investment Research Advisors first reported a position in Guardion Health Sciences, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Guardion Health Sciences, Inc. Common Stock position peaked at $51K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.